• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷霉素穿过未发炎和发炎脑膜进入脑脊液的情况。

Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges.

作者信息

Kühnen E, Pfeifer G, Frenkel C

机构信息

Institut für Medizinische Mikrobiologie und Immunologie, Universitätsklinik Bonn.

出版信息

Infection. 1987 Nov-Dec;15(6):422-4. doi: 10.1007/BF01647220.

DOI:10.1007/BF01647220
PMID:3436673
Abstract

Serum and cerebrospinal fluid (CSF) concentrations of fosfomycin were evaluated in 45 patients. Mean serum concentration was 260.1 mg/l at 15 min postinfusion in 35 patients receiving a 5 g bolus dose, and 440 mg/l in five patients receiving a 10 g bolus dose. Mean distribution volume was 18.5 l (5 g dose), the total clearance was 118.8 ml/min, half-life was nearly 2 h, and the determined AUC were 420.95 mg/l.h (5 g dose) and 423.57 mg/l.h (10 g dose). The average peaks at 360 min in CSF reached 11.6 mg/l (5 g dose) and 17.7 mg/l (10 g dose). The CSF/serum ratio was 9.24% (5 g dose), and 13.81% (10 g dose). The CSF levels were not below 30 mg/l from the second day on in patients receiving 3 X 5 g fosfomycin per day. Meningeal inflammation increased the CSF concentrations from 30 mg/l at 6 h up to 150 mg/l at 120 h in the saturation phase, e. g., up to 300% more in comparison to non-inflamed meninges.

摘要

对45例患者的磷霉素血清和脑脊液(CSF)浓度进行了评估。35例接受5g静脉推注剂量的患者在输注后15分钟时的平均血清浓度为260.1mg/L,5例接受10g静脉推注剂量的患者为440mg/L。平均分布容积为18.5L(5g剂量),总清除率为118.8ml/min,半衰期约为2小时,测定的AUC分别为420.95mg/L·h(5g剂量)和423.57mg/L·h(10g剂量)。脑脊液在360分钟时的平均峰值在5g剂量组达到11.6mg/L,10g剂量组达到17.7mg/L。脑脊液/血清比值在5g剂量组为9.24%,10g剂量组为13.81%。每天接受3×5g磷霉素治疗的患者从第二天起脑脊液水平不低于30mg/L。在饱和期,脑膜炎症使脑脊液浓度从6小时时的30mg/L增加到120小时时的150mg/L,例如,与未发炎的脑膜相比增加了多达300%。

相似文献

1
Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges.磷霉素穿过未发炎和发炎脑膜进入脑脊液的情况。
Infection. 1987 Nov-Dec;15(6):422-4. doi: 10.1007/BF01647220.
2
Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges.头孢匹罗在非炎性脑膜患者中的脑脊液穿透情况。
J Antimicrob Chemother. 1992 Apr;29 Suppl A:51-7. doi: 10.1093/jac/29.suppl_a.51.
3
Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges.环丙沙星在有炎症和无炎症脑膜患者脑脊液中的穿透情况。
Eur J Clin Microbiol Infect Dis. 1991 Jun;10(6):511-4. doi: 10.1007/BF01963940.
4
Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin.
Int J Clin Pharmacol Res. 1985;5(3):171-4.
5
[Fosfomycin levels in the cerebrospinal fluid of patients with and without meningitis].
Immun Infekt. 1987 May;15(3):98-102.
6
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.头孢噻肟和头孢曲松在未发炎脑膜患者脑脊液中的透过情况。
Antimicrob Agents Chemother. 1993 Jul;37(7):1518-24. doi: 10.1128/AAC.37.7.1518.
7
[Meningeal diffusion of cefpirome in adults].
Pathol Biol (Paris). 1989 May;37(5):442-5.
8
A study of the levels of fosfomycin in the cerebrospinal fluid in adult meningitis.
Chemotherapy. 1977;23 Suppl 1:180-8. doi: 10.1159/000222045.
9
The passage of fosfomycin into the cerebrospinal fluid in children's meningitis.
Chemotherapy. 1977;23 Suppl 1:189-95. doi: 10.1159/000222046.
10
Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.利福平在脑膜未发炎的成人脑脊液中的渗透情况。
J Antimicrob Chemother. 1992 Jun;29(6):719-24. doi: 10.1093/jac/29.6.719.

引用本文的文献

1
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study.静脉注射磷霉素的真实世界应用、有效性及安全性:FORTRESS研究
Infect Dis Ther. 2025 Apr;14(4):765-791. doi: 10.1007/s40121-025-01125-2. Epub 2025 Mar 19.
2
Fosfomycin-Containing Regimens for the Treatment of Central Nervous System Infections in a Neonatal Intensive Care Unit: A Case Series Study.含磷霉素方案治疗新生儿重症监护病房中枢神经系统感染:病例系列研究
Antibiotics (Basel). 2024 Jul 18;13(7):667. doi: 10.3390/antibiotics13070667.
3
Reintroduction of Legacy Antibiotics in Neonatal Sepsis: The Special Role of Fosfomycin and Colistin.

本文引用的文献

1
[Cerebrospinal fluid (CSF) levels of chloramphenicol: a critical review (author's transl)].
Neurochirurgia (Stuttg). 1980 Nov;23(6):235-8. doi: 10.1055/s-2008-1053889.
2
[Gentamicin concentrations in cerebrospinal fluid of patients with inflamed and uninflamed meninges (author's transl)].[患有炎症性和非炎症性脑膜的患者脑脊液中的庆大霉素浓度(作者译)]
Infection. 1980;8(2):86-9. doi: 10.1007/BF01639153.
3
[Transfer of fosfomycin into the cerebrospinal fluid].
Jpn J Antibiot. 1982 Nov;35(11):2530-4.
4
传统抗生素在新生儿败血症中的重新应用:磷霉素和黏菌素的特殊作用
Antibiotics (Basel). 2024 Apr 5;13(4):333. doi: 10.3390/antibiotics13040333.
4
Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study.脑室炎患者中磷霉素的脑脊液穿透性:一项观察性研究。
Ann Clin Microbiol Antimicrob. 2023 Apr 24;22(1):29. doi: 10.1186/s12941-023-00572-4.
5
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I.重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第一部分
Antibiotics (Basel). 2022 Aug 29;11(9):1164. doi: 10.3390/antibiotics11091164.
6
IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis.疑似临床败血症新生儿静脉注射和口服磷霉素的药代动力学
J Antimicrob Chemother. 2021 Jun 18;76(7):1855-1864. doi: 10.1093/jac/dkab083.
7
Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods - ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii.细菌感染的肠外初始治疗方案:多重耐药革兰氏阴性杆菌感染——产超广谱β-内酰胺酶菌、产碳青霉烯酶肠杆菌科细菌、耐碳青霉烯鲍曼不动杆菌。
GMS Infect Dis. 2020 Mar 26;8:Doc04. doi: 10.3205/id000048. eCollection 2020.
8
The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria.磷霉素在治疗多重耐药性败血症方面的潜力:体外分析对侵袭性儿科革兰氏阴性菌的活性。
J Med Microbiol. 2019 May;68(5):711-719. doi: 10.1099/jmm.0.000973. Epub 2019 Apr 17.
9
Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.中枢神经系统药物的临床药代动力学和药效动力学。
Clin Pharmacokinet. 2018 Sep;57(9):1059-1074. doi: 10.1007/s40262-018-0632-y.
10
[Antibiotic diffusion to central nervous system].[抗生素向中枢神经系统的扩散]
Rev Esp Quimioter. 2018 Feb;31(1):1-12. Epub 2018 Jan 31.
Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis.
Chemotherapy. 1981;27(6):405-13. doi: 10.1159/000238009.
5
Phosphonomycin: structure and synthesis.磷霉素:结构与合成
Science. 1969 Oct 3;166(3901):123-5. doi: 10.1126/science.166.3901.123.
6
Clinical pharmacology and in vitro activity of phosphonomycin.
Antimicrob Agents Chemother (Bethesda). 1969;9:332-7.
7
[Fosfomycin levels in the cerebrospinal fluid of patients with and without meningitis].
Immun Infekt. 1987 May;15(3):98-102.
8
The penetration of doxycycline into CSF.
Scand J Infect Dis Suppl. 1976(9):17-9.
9
Fosfomycin in chronic urinary infections.磷霉素治疗慢性泌尿系统感染
Chemotherapy. 1977;23 Suppl 1:267-74. doi: 10.1159/000222059.
10
Treatment of respiratory infections with fosfomycin.用磷霉素治疗呼吸道感染。
Chemotherapy. 1977;23 Suppl 1:343-7. doi: 10.1159/000222074.